Skip to main content

Duke oncology spin-out raises stakes for polio-based cancer treatment

The pieces are starting to fall into place at a Duke University spin-out studying how technology derived from a polio vaccine might cure hard-to-treat cancers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.